AstraZeneca: Solid Earnings Report Reinforces Medium To Long Term Upside (NASDAQ:AZN)

A big sign with AstraZeneca logotype outside the entrance.

Wirestock/iStock Editorial via Getty Images

Since the last time I covered the pharmaceuticals giant AstraZeneca (NASDAQ:AZN) (OTCPK:AZNCF) in May this year, its share price is almost back to where it was when I wrote.

Even at the time, there seemed little

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *